Abstract :
A serious problem in the culture of animal cells to produce therapeutic proteins is apoptosis (programmed cell death) because it restricts the ability of the cell culture to yield the heterologous material. One means to delay apoptosis is genetically to engineer the anti-apoptotic gene bcl-2 into the genome. This had been adopted elsewhere to give TB/C3 hybridoma cells that overexpressed bcl-2 (pEF bcl-2-MC1neopA plasmid) and a control, pEF, which contained a nonsense sequence (pEF-MC1neopA). In the spinner cultures used in the present investigation, bcl-2 cells grew for 60 h to give greater cell density at a faster specific rate and with prolonged better viability than the controls in which, after 36 h, the membrane integrity and the apoptotic index of the cells declined rapidly leading to death. Prior to 36 h, production of the monoclonal antibody was only slightly higher in the pEF control giving little evidence for the metabolic burden of its production on antibody synthesis. Bcl-2 synthesis, however, was associated with 125% increase in heat flow rate (HFR) measured in the chemically (triacetin) calibrated batch microcalorimeter. HFR is a function of the metabolic rate and it is suggested that its greater level in the bcl-2 cells than the control was caused by the increased protein production due to the bcl-2 gene expression. The bcl-2 cells had an increased lactate flux compared with the control. The calorimetric–respirometric (CR) ratio confirmed the likelihood that glycolysis rather than glutaminolysis was the primary reason for this increase. It may be due to the limitation in mitochondrial capacity and/or the paucity of biosynthetic precursors leading to production of them from glucose.
